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Telomerase is an enzyme that replaces repetitive (TTAGGG)n
sequences on ends of chromosomes that otherwise are lost with
successive cell divisions (Grieder et al, 1985). As a result telom-
erase activity is linked closely to attainment of cellular immor-
tality, a step in carcinogenesis, while lack of such activity
contributes to cellular senescence (Kim et al, 1994; Shay et al,
1997). Recently, genes encoding three major components of
human telomerase have been cloned, specifically human
telomerase RNA component (hTR) (Feng et al, 1995), human telom-
erase reverse transcriptase (hTERT) (Nakamura et al, 1997;
Meyerson et al, 1997), and telomerase-associated protein-1
(TEP1) (Harrington et al, 1997; Nakayama et al, 1997). Other
recently cloned sequences code for human telomeric-repeat
binding proteins, such as human telomeric-repeat binding factor
protein (TRF) 1 and 2 (Chong et al, 1995; Broccoli et al, 1997). 
Expression of these genes can now be studied and could be thera-
peutically altered. However, details of mechanisms regulating telom-
erase activity are still poorly understood, and, as a result, the specific
components or binding proteins that might represent suitable targets
for cancer gene therapy have not been identified. Since expression
levels of these genes have been studied by varying methods of
Northern blotting or reverse transcription-polymerase chain reaction
(RT-PCR) that make comparisons difficult (Feng et al, 1995;
Nakamura et al, 1997; Meyerson et al, 1997; Harrington et al,
1997; Nakayama et al, 1997; Broccoli et al, 1997; Nakayama et al,
1998; Ito et al, 1998; Takakura et al, 1998; Kyo et al, 1999), we
performed novel quantitative assays using a TaqMan RT-PCR for
the telomerase components hTR, hTERT and TEP1 as well as for
TRF1 and TRF2 (Yajima et al, 1998; Yajima et al, 2000). 
Radiation induces cellular damage at DNA level. A possible
role of telomerase activity in radiation induced cellular damage is
to maintain the integrity of the genome including telomeric region.
Low dose of X-irradiation induces up-regulation of telomerase
activity (Hyeon et al, 1998). However, little is known about the
effect of X-irradiation to the transcription of these telomerase
components and TRFs. 
To clarify mechanisms regulating telomerase activity, we
studied telomerase activity, telomere length and gene expression
of these telomerase components and the TRFs in sequential
observation following X-irradiation of cultured cells. 
MATERIALS AND METHODS 
Cells 
The human pancreatic cancer cell lines PANC-1, and MIA PaCa-2,
were obtained from the American Type Culture Collection
(ATCC; Manassas, VA). PANC-1 cells are better able to tolerate
thermal stress, antineoplastic drugs, and exposure to tumour
necrosis factor than MIAPaCa-2 cells, as reported previously
(Watanabe et al, 1996; Watanabe et al, 1997). We therefore, used
these two different cell lines in the present study. PANC-1 cells
were cultured in RPMI 1640 medium supplemented with 10%
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heat-inactivated FCS. MIAPaCa-2 cells were cultured in
Dulbecco’s modified Eagle’s medium (Nipro) supplemented with
10% heat-inactivated FCS and 2.5% heat-inactivated horse serum. 
Irradiation 
PANC-1 or MIAPaCa-2 cells (5 × 106) were seeded into tissue
culture dishes 100 mm in diameter (Falcon, Oxnard, CA) containing
10 ml of culture medium. After a 6-h incubation, the culture
medium was changed and cells were X-irradiated with a dose of 10,
20, or 30 Gy. X-irradiation was carried out at room temperature
using an MBR-1520A-TW device (20 mA, 150 kV; Hitachi
Medical, Tokyo, Japan) at a dose rate of 2.089 Gy/min. Cells were
harvested for either quantitative RT-PCR assay or assay for telom-
erase activity preceding irradiation or after and 1, 2, 4, 6, or 8 days. 
Telomerase assay 
Cells were trypsinized and collected as pellets after centrifugation at
1000 × g for 5 min at 4˚C. The pellets then were washed and lysed
as described previously (Kim et al, 1994). After incubation on ice
for 30 min, lysates were centrifuged at 16 000 × g for 30 min at 4˚C.
Supernatants were collected and their protein concentrations were
measured by a Gene Quant DNA/RNA Calculator (Pharmacia,
Camblidge, UK); lysates contained 0.06 µ g of cellular protein.
Telomerase activity was measured using a PCR-based TRAP-eze
Telomerase Detection Kit (Oncor, Gaithersburg, MD) according to
the manufacturer’s instructions. Briefly, for end-labeling of TS
primer, 10 µ l of TS primer (5′ -AATCCGTCGAGCAGAGTT-3′ )
was added to 10 µ l reaction mixture including 10 µ Ci of [γ -32P] ATP
(3000 Ci/mmol; Amersham, Cambridge, UK), 2 µ l of 10 × kinase
buffer (Takara, Kyoto, Japan), 5 U of T4 polynucleotide kinase, and
5 µ l of distilled (d) H2O. The mixture was incubated for 20 min at
37˚C and then for 5 min at 85˚C. One microlitre of this primer
mixture was added to a reaction mixture containing 5 µ l of 10 ×
TRAP buffer, 1 µ l of 50 × dNTPs, 2 µ l of TS end-labeling primer,
1 µ l of TRAP primer mix, 2 U of Taq DNA polymerase (Takara),
38.6 µ l of dH2O, and 2 µ l of CHAPS extract (total volume, 50 µ L).
Each TRAP reaction mixture was incubated at 30˚C for 30 min
followed by 27 cycles of 94˚C for 30 s and 60˚C for 30 s in a thermal
cycler (model 9600; Perkin-Elmer, Foster City, CA). Fifteen
microlitres of the PCR product was electrophoresed in 0.5 × Tris-
borate EDTA buffer on 12.5% polyacrylamide nondenaturing gels.
Gels were dried and processed for autoradiography, exposing sensi-
tive New A film (Konica, Tokyo, Japan) at –80˚C for 3 h. Signal
intensity on exposed films was measured using Personal
Densitometer model SI (Molecular Dynamics, Sunnyvale, CA). The
experimental sample was incubated at 85˚C for 10 min prior to the
TRAP assay to inactivate telomerase and serve as a negative control,
and a cell extract of known telomerase content provided in the kit
served as a positive control. 
Semiquantitative analysis to estimate relative telomerase activity
was accomplished by performing the TRAP assay with a TSR8
control template provided in the kit in place of sample
extract. Telomerase activity was calculated as unit indicated total
product generated (TPG) using a formula as described previously
(Kim et al, 1997): TPG = {[(x - x0)/c]/[(r - r0)/cR]} × 100, where 
telomerase products from non-heat-treated sample extract were x,
telomerase products from a heat-treated sample extract were x0, a
non-heat-treated sample extract as an internal control was c,
telomerase product TSR8 quantification control was r, telomerase
products from the lysis buffer only was r0, and the internal control
for TSR8 quantification was cR. 
Southern blotting and terminal restriction fragment
(TRF) length analysis 
Genomic DNA was extracted from cells by using SepaGene (Sanko
Pure Chemical). 10 µ g of DNA was digested with HinfI (Sigma) at
37˚C for 4 h and electrophoresed on 1% agarose gells. The digested
DNAs were then blotted on to nylon membranes (Boehringer,
Mannheim, Germany) and hybridized with 32P-labelled (TTAGGG)4
probe. The hybridized blots were washed and then autoradiographed
as reported previously (Hiyama et al, 1996). We estimated the mean
length of terminal restriction fragments at the peak position of
hybridization signal using Personal Densitometer model SI. 
Quantitative RT-PCR assays for hTR, hTERT mRNA,
TEP1 mRNA, TRF1 mRNA, and TRF2 mRNA 
Cells were trypsinized and the cell pellets were collected by centrifu-
gation at 1000 × g for 5 min at 4˚C. SepaGene RV-R (Sanko Pure
Chemical, Tokyo, Japan) was used to extract total RNA from
cells, and this extract was assayed for RNA with 
Gene Quant DNA/RNA Calculator (Pharmacia). Contaminating
chromosomal DNA was digested with DNAse I (GIBCO-BRL,
Gaithersburg, MD) according to the manufacturer’s instructions. For
quantitative RT-PCR, fluorescent hybridization probes, TaqMan PCR
Core Reagents Kit with AmpliTaq Gold (Perkin-Elmer) were used
with the ABI Prism 7700 Sequence Detection System (Perkin-
Elmer). Expression of hTR, hTERT mRNA and TEP1 mRNA were
quantified by methods previously reported (Yajima et al, 1998;
Yajima et al, 2000). Expression of TRF1 and TRF2 mRNA was quan-
tified using a method similar to that for hTR, hTERT mRNA and
TEP1 mRNA (Yajima et al, 1998; Yajima et al, 2000). Primers and
TaqMan probes for TRF1 and TRF2 mRNA were as follows.
Sequences of the forward primer for TRF1 mRNA were 5′ -
GCAACAGCGCAGAGGCTATTATT-3′ and the reverse primer, 5′ -
AGGGCTGATTCCAAGGGTGTAA-3′ ; the sequence of the
TaqMan probe was 5′ -TCCAGTCTAACAGCTTGCCAGTTGA-
GAACG-3′ . Sequences of the forward primer for TRF2 mRNA were
5′ -AAACGAAAGTTCAGCCCCG-3′ and the reverse primer, 5′ -
TCCTCCAAGACCAATCTGCTTA-3′ ; the sequence of the 
TaqMan probe was 5′ -CAGCCCAAGAACAAGCGCATGACA-3′ .
Conditions of one-step RT-PCR were as follows: 30 min at 48˚C
(stage 1, reverse transcription), 10 min at 95˚C (stage 2, RT inactiva-
tion and AmpliTaq Gold activation), and then 40 cycles of amplifica-
tion for 15 s at 95˚C and 1 min at 60˚C (stage 3, PCR). Data for hTR,
hTERT mRNA, TEP1 mRNA, TRF1 mRNA, and TRF2 mRNA were
normalized to data for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). 
RESULTS 
Changes in cell number; telomerase activity, and gene
expression for telomerase components in MIAPaCa-2
and PANC-1 cells after X-irradiation 
To manipulate telomerase activity, MIAPaCa-2 and PANC-1 cells
were X-irradiated with dose of 10, 20, or 30 Gy. Figure 1 shows
cell numbers just before and at 1, 2, 4, 6, and 8 days following 
X-irradiation. Under all conditions, PANC-1 cells were more
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resistant to X-irradiation than MIAPaCa-2 cells. Time courses of
telomerase activity and gene expression for the telomerase compo-
nents were examined after 20 Gy irradiation. Two days after irradia-
tion, telomerase activity of MIAPaCa-2 and PANC-1 cells
respectively increased to 134.1% and 160.2% of pre-irradiation
activity, and then gradually fell to 13.5% and 10.4% of baseline
by 8 days after irradiation (Figure 2). As for gene expression of
telomerase component genes, the level of hTERT mRNA
expression peaked 2 days after irradiation, and later decreased
gradually (Figure 3), a sequence similar to that for changes in
telomerase activity. In contrast, hTRand TEP1 mRNA expression
increased gradually after X-irradiation (Figures 4 and 5). These
results suggest that expression of hTERT may play important role for
regulation of telomerase activity. We examined time courses of
telomerase activity after 10 and 30 Gyirradiation. After 10 Gy
irradiation, telomerase activity did not decrease to less than 50% of
that in cells just before X-irradiation, and after 30 Gy, the cell number
at 8 days was not enough to examine telomerase activity, expression
of its component and TRF length. 
Telomeric restriction fragment (TRF) length in
MIAPaCa-2 and PANC-1 cells after X-irradiation 
To elucidate whether the change of telomeric length occurs after
X-irradiation, the telomeric restriction fragment (TRF) which is 
an indicator of telomeric length was examined by Southern
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Figure 1 Cell numbers surviving over time after X-irradiation (10, 20, or
30 Gy). PANC-1 cells were more resistant to irradiation than MIAPaCa-2 cells 
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Figure 3 Expression of hTERT mRNA over time after 20 Gy of X-irradiation
to MIAPaCa-2 and PANC-1 cells. Expression of hTERT mRNA was
measured by a quantitative TaqMan RT-PCR assay, and is stated relative to
that of glyceraldehyde-3-phosphate dehydrogenase. Relative hTERT mRNA
expression is calculated as a relative percentage of cells just before 
X-irradiation. hTERT, human telomerase reverse transcriptase
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Figure 4 Expression of hTR over time after 20 Gy of X-irradiation to
MIAPaCa-2 and PANC-1 cells. Expression of hTR was quantified by a
quantitative TaqMan RT-PCR assay, and is stated relative to that of
glyceraldehyde-3-phosphate dehydrogenase. Relative hTR expression is
calculated as a relative percentage of cells just before X-irradiation. hTR,
human telomerase RNA component 
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hybridization assay. Figure 6 shows TRF length just before and at
1, 2, 4, 6, and 8 days following X-irradiation. TRF length was
stable between 2.7 and 2.8 kb, 2.5 and 2.6 kb in MIAPaCa-2 and
PANC-1 cells, respectively. 
Telomerase activity and gene expression for telomeric-
repeat binding factors in MIAPaCa-2 and PANC-1 cells
after X-irradiation 
To clarify the relationship between telomerase activity and telomere
binding protein gene expression, MIAPaCa-2 and PANC-1 cells
were X-irradiated with a dose of 20 Gy and changes were observed
over time. Expression of TRF1 mRNA showed a peak 1 day after
irradiation, and then decreased gradually (Figure 7), as did telom-
erase activity. TRF2 mRNA decreased gradually after X-irradiation
(Figure 8), representing a smaller change than for TRF1 showing no
correlation with telomerase activity. 
DISCUSSION 
Expression of hTR and TEP1 mRNA has been detected not only in
cancer cells with high levels of telomerase activity but also in non-
neoplastic cells (Nakayama et al, 1998; Ito et al, 1998; Takakura 
et al, 1998). In contrast, many studies have found expression of
hTERT mRNA to be limited to cancer cells (Nakamura et al, 1997;
Meyerson et al, 1997; Nakayama et al, 1998; Takakura et al,
1998). In addition, in recent investigations where hTERT and hTR
genes were transfected into normal cells, the cells acquired ability
to restore telomeres, and the lifespan of the cell culture was
extended by population doubling level (Weinrich et al, 1997;
Bodnar et al, 1998). Even hTERT transfected by itself could recon-
stitute telomerase activity (Nakayama et al, 1998; Vaziri 
et al, 1998). Accordingly, hTERT appears to be the main factor
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Figure 5 Expression of TEP1 mRNA over time after 20 Gy of X-irradiation
to MIAPaCa-2 and PANC-1 cells was measured by a quantitative TaqMan
RT-PCR assay. Expression is stated relative to that of glyceraldehyde-3-
phosphate dehydrogenase, and relative TEP1 mRNA expression is
calculated as a relative percentage of cells just before X-irradiation. TEP1,
telomerase-associated protein-1 
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Figure 6 Telomeric restriction fragment (TRF) length in MIAPaCa-2 and PANC-1 cells before and after X-irradiation. TRF length was determined by the
Southern hybridization assay using radioactively labelled TTAGGG probe 
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permitting regulation of telomerase activity. However, recent
studies have detected expression of hTERT mRNA in normal cells
(Ito et al, 1998; Kolquist et al, 1998). Precise comparison of
expression levels of these telomerase component genes between
studies often is difficult because of differences between Northern
blotting and RT-PCR methods. 
Hyeon et al, have reported increased telomerase activity
of human colon carcinoma cell line (SW480) and human
nonpolyposis colorectal carcinoma (HNPCC) cell lines
(NA50600, NA59 and NA61) was observed at 24 h after 2 or 4
Gy X-irradiation (Hyeon et al, 1998). But, there are no previous
reports that showed telomerase activity, telomere length and gene
expression of these telomerase components and the telomeric-
repeat binding factor proteins in sequential observation following
X-irradiation of cultured pancreatic cancer cells. We used X-ray
irradiation (10, 20, and 30 Gy) to trigger the telomerase modulating
effects upon the pancreatic cells and this is presumably to effect
a fixed level of induced damage at the DNA level. In addition, we
used low dose X-ray irradiation (1, 3, and 5 Gray) to trigger the
telomerase modulating effects, but these doses were too weak to
modulate the time-courses of the telomerase expression.
Cytotoxic effect of 20 Gy X-irradiation is weaker than that of
1 M Adriamycin (Watanabe et al, 1997). 
To examine the telomerase activity and its regulation, we exam-
ined the time course of changes in telomerase activity and gene
expression for human telomerase components using a quantitative
RT-PCR assay with a TaqMan fluorogenic detection system in 
X-irradiated pancreatic cancer cell lines, finding only hTERT
mRNA to parallel telomerase activity. Expression of hTR and
TEP1 mRNA increased gradually after X-irradiation, why this
occurred are unclear, but these component have a much smaller
role to play for telomerase activity, if any. Under all conditions,
PANC-1 cells were more resistant to X-irradiation than MIAPaCa-
2 cells. But our results found MIAPaCa-2 to parallel PANC-1 in
time-course of telomerase activity, expression of its components
and telomere length after X-irradiation, and indicate that telom-
erase and telomere length do not play a role in the differential
radiosensitivity of these two cell lines. 
More recently, genes encoding TRF1 and TRF2 have been
cloned (Chong et al, 1995; Broccoli et al, 1997). TRF1 reportedly
inhibits the action of telomerase at the telomeric region (van
Steensel et al, 1997), and TRF2 prevents fusion of chromosome
ends and, in vitro, to remodel linear telomeric DNA into large
duplex loops (van Steensel et al, 1998; Griffith et al, 1999).
However, the functional relationship between telomerase activity
and gene expression for TRFs in elongation of the telomere has
not been clarified. We therefore examined the time course of the
telomere length and gene expression for TRFs after irradiation of
the cultures. After irradiation, expression of TRF1 decreased
when telomerase activity decreased, a change consistent with the
function of maintaining a fixed telomere length. This interpreta-
tion is in agreement with our data that telomere length was stable
in MIAPaCa-2 and PANC-1 cells before and after X-irradiation,
and a previous report that cancer cells have a fixed telomere
length regardless of division frequency (van Steensel et al, 1997;
Counter et al, 1992). TRF1 plays an important role in determining
telomere length in cancer cell lines, as TRF1 controls binding of
the enzyme to the chromosomal region involved. In this study,
TRF2 mRNA decreased gradually after X-irradiation. Hande et al.
have reported increased frequencies of dicentricism and translo-
cation along with other types of chromosomal aberrations
following X-irradiation (Hyeon et al, 1998; Hande et al, 1998).
Fusion of the chromosomal end after X-irradiation might result
from such a decrease of TRF2. 
Given the correlations observed in cancer cell lines in our study,
it is demonstrated that not only hTERT but also TRF1 may play
important role of telomerase activity. 
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